Joint Clinical Trials Office
A Study of Dato-DXd With or Without Durvalumab Versus Investigator's Choice of Therapy in Patients With Stage I-III Triple-negative Breast Cancer Without Pathological Complete Response Following Neoadjuvant Therapy (TROPION-Breast03)
Study Status:
Open to Enrollment
Primary Investigator:
Date: December 5, 2023
Rosuvastatin Efficacy and Safety for Cirrhosis in the United States (RESCU): A Double-Blind Randomized, Placebo-Controlled Phase 2 Study
Study Status:
Open to Enrollment
Primary Investigator:
Date: December 11, 2023
A Real World Study of eCoin® for Urgency Urinary Incontinence: Post Approval Evaluation (RECIPE)
Study Status:
Open to Enrollment
Primary Investigator:
Date: December 11, 2023
A Phase II Randomized Control Trial of Triapine Plus Lutetium Lu 177 Dotatate Versus Lutetium Lu 177 Dotatate Alone for Well-Differentiated Somatostatin Receptor-Positive Neuroendocrine Tumors
Study Status:
Open to Enrollment
Primary Investigator:
Date: December 21, 2023
Inventiva 337HNAS20011 (NATiV3): A randomised, double-blind, placebo-controlled, multicentre, Phase 3 study evaluating efficacy and safety of lanifibranor followed by an active treatment extension in adult patients with non-cirrhotic non-alcoholic steatoh
Study Status:
Open to Enrollment
Primary Investigator:
Date: December 28, 2023
A Pragmatic Observational Study of Biometrics Collected by Wearable Technology in Patients with Liver Disease
Study Status:
Open to Enrollment
Primary Investigator:
Date: December 28, 2023
Multi-modal neuroimaging and cognitive assessment of females with multiple sclerosis across different stages of menopause
Study Status:
Open to Enrollment
Primary Investigator:
Date: January 2, 2024
The Janus Rectal Cancer Trial: A Randomized Phase II Trial Testing the Efficacy of Triplet Versus Doublet Chemotherapy to Achieve Clinical Complete Response in Patients with Locally Advanced Rectal Cancer
Study Status:
Open to Enrollment
Primary Investigator:
Date: January 3, 2024
Pain Reduction Using NEurostimulation (PRUNE) Study
Study Status:
Open to Enrollment
Primary Investigator:
Date: January 8, 2024
Diet and Meal Timing in Patients with Non-Alcoholic Fatty Liver Disease: A Pilot Study
Study Status:
Open to Enrollment
Primary Investigator:
Date: January 10, 2024